$XRP Pharmaceutical company Wellgistics integrates XRP into payment operations.

Pharmaceutical company Wellgistics Health Inc. has announced a credit line of $50 million for the integration of XRP into its financial operations. The goal of this initiative is to increase transaction speed and transparency within its network.

As a result, XRP will be used as a treasury reserve asset and real-time payment medium, making Wellgistics one of the first publicly traded medical companies with such integration.

Transaction processing on the XRP ledger takes 3–5 seconds at a cost of less than $0.0002 — this is a significant advantage over bank payments.

CEO Brian Norton, who has already secured over 150 direct contracts with manufacturers and has a network of more than 6000 pharmacies nationwide, emphasized that this step promotes the modernization of payments in the healthcare system.

It is quite likely that institutional adoption of XRP was spurred by the launch of XRP futures by CME Group and the recognition of the token by payment giant Mastercard (NYSE:MA) as an intermediary currency for cross-border payments.